Abstract
Multiple sclerosis (MS) is a serious neurological disorder leading without treatment to irreversible disability. Diagnostic process may be rapid enough if the symptoms are not underestimated and MS is considered.
Both early start of immunomodulatory treatment and early administration of methylprednisolon in case of acute attack reduce tissue damage in MS. Patient's quality of life depends also on adverse events prevention and symptomatic treatment